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Systemic lipopolysaccharide (LPS) is implicated in increasing mortality in patients with alcoholic 
hepatitis but the underlying mechanisms are not well characterised. The objective of this study was to 
characterise neutrophil function, LPS and cytokine concentrations within the splanchnic circulation 
of alcoholic cirrhotic patients undergoing TIPSS insertion for variceal haemorrhage and correlate this 
with outcome. 26 patients with alcoholic cirrhosis and variceal haemorrhage were studied prior to and 
1-hour after TIPSS insertion. Neutrophil function, LPS and cytokine concentrations were determined 
in arterial, hepatic venous (HV) and portal venous blood (PV). Significantly higher LPS concentrations 
and neutrophil reactive oxidant species (ROS) production were observed in PV vs HV blood. Cross-
incubation of HV plasma with PV neutrophils resulted in reduced ROS production. Insertion of TIPSS 
was associated with a significant increase in arterial LPS concentrations and deterioration in neutrophil 
phagocytosis. Number of organ failures and arterial IL-6 concentrations at presentation were associated 
with increased mortality. The portal circulation has a distinct immunological milieu characterised 
by a pathological neutrophil phenotype and an anti-inflammatory cytokine profile associated with 
heightened LPS levels. TIPSS insertion renders this neutrophil functional defect systemic, associated 
with an increase in arterial LPS and a susceptibility to sepsis.
Variceal haemorrhage is a common and life-threatening complication of cirrhosis. A growing body of evi-
dence suggests the presence of a dynamic, modifiable component of portal hypertension consequent upon 
LPS (LPS)-induced inflammation, typically observed in an acute context. In cirrhotic rats, administration of 
intra-peritoneal LPS (LPS) has been shown to increase portal pressure1 and toll-like receptor 4 deficient mice are 
protected from portal hypertension following bile duct ligation2. Selective intestinal decontamination is associ-
ated with an improvement in vascular resistance and reduction in portal pressure3.
The relevance of LPS-induced inflammation in the context of variceal bleeding is evidenced clinically by the 
observed reduction in mortality and re-bleeding rates following administration of prophylactic antibiotics4,5. 
The central role of inflammation-driven portal hypertension is further demonstrated by the observed decrease 
in hepatic venous pressure gradient (HVPG) in patients with severe alcoholic hepatitis treated with anti-TNF 
(Tumour Necrosis Factor) α therapy6. Furthermore, correlations between pro-inflammatory mediators C-reactive 
protein and IL-6 and portal pressure and mortality have been observed7–9. The influence of the resultant systemic 
inflammation on intra-hepatic resistance is most marked in patients with more advanced disease, in particular, 
acute on chronic liver failure (ACLF)10; yet little is understood regarding underlying mechanisms. More recently, 
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LPS levels were shown to increase the mortality of patients with alcoholic hepatitis11 but the mechanisms of how 
LPS leads to increased mortality is unknown.
A previous study from this group12 described a significant deterioration in neutrophil ROS production follow-
ing TIPSS insertion for refractory variceal haemorrhage suggestive of a differential portal and systemic immu-
nological milieu. We have also shown that LPS may contribute to this neutrophil dysfunction supporting the 
hypothesis that the observed relationship between LPS levels and mortality may be due to its effect on neutrophil 
function. Insertion of TIPSS allows simultaneous access to the hepatic and portal veins and, the systemic cir-
culation allowing sampling of these vascular beds. The primary objective of this study was to characterise the 
differential nature of the innate immune response and LPS concentrations within the splanchnic vascular beds 
to determine to what extent they are compartmentalised within the portal circulation and rendered systemic by 
TIPSS insertion. We studied alcoholic cirrhotic patients undergoing TIPSS insertion indicated for refractory 
variceal haemorrhage. Neutrophil function, LPS levels and cytokine profile were determined in the portal and 
hepatic veins pre-TIPSS insertion together with the effect of cross-incubation of hepatic or portal venous plasma 
on portal and hepatic venous neutrophil function. By sampling the arterial inflow, we were able to calculate 
fractional extraction of LPS by the liver and intestine to ascertain the contribution of these organ systems to LPS 
kinetics. A further objective of this study was to determine which of these laboratory or clinical variables have 
prognostic relevance in the context of refractory variceal haemorrhage. We therefore sought to determine the 
associations of pro-inflammatory indices and organ failure with 30, 60 and 90-day mortality in this patient cohort 
to ascertain the prognostic significance of these factors.
Results
Patient characteristics. Twenty-six patients with alcoholic cirrhosis underwent TIPSS insertion indicated 
for variceal haemorrhage refractory to standard endoscopic therapy were the subjects of this study. The patient 
characteristics at the time of TIPSS insertion are summarized in Table 1. The mean age of the patient cohort was 
49.62 (± 2.45) years with a male: female ratio of 16:10. The mean MELD score of the patients in this study was 21.46 
(± 1.40) with ascites present in 19 patients with a mean West Haven score of 1.62 (± 0.18). The mean laboratory 
values were as follows: INR 1.89 (± 0.08), bilirubin 111.60 (± 15.39) μ mol/L, creatinine 125.80 (± 13.68) μ mol/L 
and albumin 27.88 (± 0.68) g/dL. Mean portal pressure gradients pre- and post-TIPSS insertion were 21.04 
(± 1.09) mm Hg and 9.58 (± 0.34) mm Hg respectively. 13 out of 26 patients died during follow-up in the study. 
Cause of death was as follows: multiple organ failure (n = 5), sepsis (n = 4), HE (n = 3). No cause of death was 
documented in 2 patients. The mean time from TIPSS insertion to death was 88.38 (+ /− 13.89) days. The mean 
follow up was 248.9 (+ /− 23.36) days in the survivor cohort.
LPS studies. Mean LPS levels in the portal vein and hepatic vein pre-TIPSS insertion were 0.15 ± 0.01 and 
0.03 ± 0.00 EU/ml respectively (p < 0.0001) (Fig. 1a). The pre-TIPSS trans-intestinal and trans-hepatic fractional 
extraction of LPS was observed to be 2.24 ± 0.47 and − 1.14 ± 0.14 respectively (Fig. 1b). TIPSS insertion resulted 
in a significant increase in arterial LPS levels from 0.06 ± 0.00 to 0.14 ± 0.01 EU/ml (p < 0.0001) (Fig. 2).
Neutrophil Function. A significant difference in neutrophil resting burst was observed between hepatic 
and portal venous neutrophils (39.23 ± 3.28 vs 86.19 ± 1.92% respectively, p < 0.0001). Hepatic venous neutro-
phil resting burst was significantly increased from 39.23 ± 3.28 to 61.23 ± 3.95% after incubation with portal 
venous plasma (p < 0.0001) (Fig. 3). Conversely portal vein neutrophil resting burst was significantly reduced 
from 86.19 ± 1.92 to 57.46 ± 2.78% (p < 0.0001) after incubation with hepatic venous plasma. A significant corre-
lation between portal venous neutrophil ROS and portal pressure gradient prior to TIPSS insertion was observed 
Patient Characteristics Mean (SEM)
Age (yr) 49.62 (2.45)
Male:Female 16:10
MELD 21.46 (1.40)
Organ failure (N/Y)
 Liver 0/26
 Kidney 14/12
 Cerebral 0/26
 Coagulation 0/26
 Ascites 19
Laboratory data
 INR 1.89 (0.08)
 Bilirubin (μ mol/L) 111.60 (15.39)
 Creatinine (μ mol/L) 125.80 (13.68)
 Albumin (g/dL) 27.88 (0.68)
Haemodynamic Data
 Pre-TIPSS PPG (mm Hg) 21.04 (1.09)
 Post-TIPSS PPG (mm Hg) 9.58 (0.34)
Table 1.  Patient characteristics at time of TIPSS insertion.
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(Pearson r = 0.521, P = 0.006) (Fig. 4). Paralleling the observed increase in arterial LPS concentrations 1-hour 
post-TIPSS insertion, peripheral neutrophil function was significantly impaired following insertion of TIPSS. 
Neutrophil phagocytic function was significantly reduced from 63.92 ± 3.37% to 44.31 ± 3.47% (p = 0.0002) 
(Fig. 5).
Cytokine studies. Portal venous IL-6 levels were significantly lower than concentrations within the hepatic 
vein (0.45 ± 0.06 vs 0.88 ± 0.09 ng/ml) (p = 0.0004) (Fig. 6a). Conversely, IL-10 (Interleukin-10) levels were 
significantly higher in the portal vein compared to hepatic vein (0.83 ± 0.07 vs 0.53 ± 0.04 ng/ml) (p = 0.004) 
(Fig. 6b). IL-6/IL-10 ratios were significantly higher in the hepatic vein compared to portal vein (1.91 ± 0.26 vs 
0.61 ± 0.08) (Fig. 6c). Arterial IL-6 concentrations were found to be predictive of mortality (supplemental data).
Predictors of Survival. Non-survivors were found to have significantly higher bilirubin and arterial IL6 
compared to survivors. No significant difference in MELD score or portal pressure gradient were observed 
Figure 1. (a) LPS concentrations in the hepatic and portal venous plasma. Significantly higher endotoxaemia is 
observed in portal venous compared to hepatic venous plasma (****p < 0.0001) (b) Trans-Intestinal and trans-
hepatic fractional extraction (FE) of LPS. Positive trans-intestinal LPS FE was observed consistent with gut-
derived endotoxaemia. Negative trans-hepatic LPS FE was observed consistent with hepatic LPS clearance.
Figure 2. Arterial LPS concentrations pre- and 1 hour post-TIPSS insertion. Significant increases in arterial 
LPS concentrations are observed 1 hour post-TIPSS insertion (****p < 0.0001).
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between the groups (Supplemental Figure). Increasing number of organ failures at presentation was associated 
with worsening 30, 60 and 90 day mortality (Fig. 7).
Discussion
Variceal haemorrhage is a common complication of cirrhosis and associated with significant mortality. Clinically, 
the course may follow one of an acute uncomplicated decompensation event or a precipitant of ACLF. The path-
ogenic mechanisms underlying these clinical phenotypes remain poorly understood but an LPS-driven dysregu-
lated inflammatory response is frequently observed and contributes to susceptibility to organ injury and immune 
Figure 3. Reactive Oxidant Species (ROS) production in hepatic venous neutrophils (HVN) with and 
without co-incubation of portal venous plasma (PVP) and portal venous neutrophils (PVN) with and 
without co-incubation with hepatic venous plasma (HVP). Significantly higher ROS production was 
observed in PVN compared to HVN (****p < 0.0001). Co-incubation of HVN with PVP conferred a heightened 
ROS phenotype (****p < 0.0001). Conversely, co-incubation of PVN with HVP attenuated the heightened ROS 
phenotype (****p < 0.0001).
Figure 4. Correlation between Portal Pressure Gradient (PPG) pre-TIPSS and Portal venous neutrophil 
ROS production. A significant correlation between portal venous neutrophil ROS and portal pressure gradient 
prior to TIPSS insertion (Pearson r = 0.521, P = 0.006).
Figure 5. Arterial neutrophil phagocytosis pre- and 1 hour post-TIPSS insertion. Significant reductions in 
arterial neutrophil ROS production were observed 1 hour post-TIPSS insertion (***p < 0.001).
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paresis. Selective intestinal decontamination has been shown to confer survival benefit in this context implicating 
gut derived bacteria or bacterial products in pathogenesis13.
A significant LPS gradient was observed across the liver between portal and hepatic venous beds prior to 
TIPSS insertion associated with high positive trans-intestinal and negative trans-hepatic fractional extraction of 
Figure 6. (a) Plasma interleukin 6 concentrations in the hepatic and portal veins (b) Plasma interleukin 10 
concentrations in the hepatic and portal veins (c) Plasma interleukin 6/10.
Figure 7. Mortality post-TIPSS insertion according to number of organ failures at the time of 
presentation. 
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LPS. This highlights that it is a defect at the gut-barrier interface, which predominantly contributes to systemic 
endotoxemia in refractory variceal haemorrhage and by implication constitutes the best target for therapy. Of 
note, the aetiology of cirrhosis in this cohort was exclusively alcoholic with no pre-determined period of absti-
nence. Patients with alcoholic cirrhosis have been shown to have significantly higher LPS concentrations than 
their non-alcoholic counterparts14. This is attributable to promotion of small intestinal bacterial overgrowth and 
direct toxic effects on the mucosa due to metabolites such as acetaldehyde15. Poor nutritional status may further 
compound this. Metabolic stressors relevant to refractory variceal haemorrhage such as oxidative injury and 
hypoxaemia may further contribute in the acute context.
In parallel to the finding of a trans-hepatic LPS gradient, we observed a ‘compartmentalization’ of neutrophil 
dysfunction, manifest by increased resting burst. Portal venous neutrophils were found to exhibit a pathologically 
heightened respiratory burst, which was significantly elevated compared to hepatic venous neutrophils, within 
a range known to be associated with excess mortality16. This neutrophil defect could be conferred or abrogated 
by co-incubation of portal venous or hepatic venous plasma respectively. Previous studies in patients with alco-
holic cirrhosis demonstrated that a humoral factor, LPS, is responsible for mediating neutrophil dysfunction, a 
finding consistent with this data16. In these studies, neutrophil dysfunction, evidenced by both heightened ROS 
production and diminished phagocytosis, was normalised upon removal of LPS by either use of polymyxin B 
columns or anti-CD14 antibodies16. Further studies from our group have demonstrated an increased surface 
expression of TLR2 and 4 on the neutrophils of cirrhotic patients17 implicating LPS in pathogenesis. Of note, this 
study did not include a control population but is comparative to previous studies from our group by use of similar 
methodology.
Portal venous neutrophil ROS production was found to significantly correlate with portal pressure gradient. 
Portal hypertension is determined by both fixed and dynamic components of intrahepatic resistance, the latter 
of which is governed by vasomotor responsiveness and levels of vasoactive mediators. It is now understood that 
inflammation can modulate these variables. An increase in oxidative stress has been shown to result in reduced 
nitric oxide bioavailability10. It follows therefore that an increase in portal neutrophil-derived reactive oxidant 
species may result in lower portal nitric oxide levels with a resultant increase in portal pressure. Validation of 
these observations and mechanisms should be the focus of future studies.
TIPSS insertion was associated with a significant rise in arterial LPS concentrations and reduction in arterial 
neutrophil phagocytosis. Research from this group12 has previously identified TIPSS insertion to be associated 
with a significant increase in neutrophil ROS production associated with an increase in arterial LPS. This was cor-
related with an increase in whole body nitric oxide production and increased iNOS activity in HUVEC cell lines. 
Clinically, this was associated with a significant increase in cardiac output and cerebral blood flow.
IL-6/IL-10 ratios were calculated as a measure of the relative pro- or anti-inflammatory cytokine response. 
Hepatic venous and arterial ratios were found to be similar however ratios in portal venous blood are more 
skewed towards an anti-inflammatory response. Positive intestinal IL-10 fractional extraction was observed con-
sistent with intestinal generation of IL-10. The most likely origin of portal-derived IL10 is from local innate 
immune populations and enterocytes. Indeed, increased interleukin-10 has been observed in the ileum of portal 
hypertensive rats18. Production of IL-10 is a key strategy lamina propria macrophages employ to induce an inhib-
itory, tolerising immunological phenotype in the gut in response to enterocyte stress. Metabolic stress is evident 
in intestinal mucosa even in the context of stable cirrhosis19. Portal hypertension with splanchnic venous stasis 
and associated hypoxia is a likely driver of this. Trafficking neutrophils may further contribute and indeed have 
been also shown to be significant IL-10 producers in the context of advanced cirrhosis16. Regulation of interleukin 
production within the mucosal-associated lymphoid tissue is complex and beyond the scope of this study.
In contrast to the intestine, the liver has a negligible role in IL-10 production but is a significant source of IL-6. 
Many different cell types within the liver including stimulated monocytes, fibroblasts and endothelial cells, gen-
erate IL-6. Hepatocytes may also be directly stimulated to produce IL-6 by factors such as bacterial LPS. Previous 
studies have demonstrated that IL-6 produced from Kupffer cells and hepatocytes following endotoxin challenge 
in alcoholic liver disease results in increased transcription of hepatoprotective pathways via STAT3, promoting 
hepatocellular proliferation in response to high portal venous endotoxin levels20.
This study highlights the prognostic relevance of organ failure and inflammatory indices in determining mor-
tality following TIPSS insertion for refractory variceal bleeding. Conceptually, this reflects current understanding 
regarding the critical role of organ failure and a systemic inflammatory response syndrome in predicting outcome 
in advanced disease reiterating findings in large-scale studies21. Indeed, Ghaoui R. et al.22 identified that ACLF 
grade was predictive of mortality in a retrospective analysis of 239 patients with portal hypertension-related 
bleeding episodes.
In contrast, conventional measures of liver function such as MELD were not found to be predictive of survival 
in this context. This finding is in contrast with that of a recent study by Casadaban et al. of 101 patients under-
going TIPSS insertion for variceal haemorrhage23. This study identified MELD score to be predictive of 90 day 
mortality. Scores of > 26, 19–25, 11–18 and < 10 were found to be associated with 90 day mortalities of 83%, 36%, 
13% and 9% respectively. Potential factors which may account for the discordance in findings relate to the differ-
ences in patient population. Of note, the MELD scores in our patient population were high with a mean value of 
21.46 ± 1.40 mm Hg. Lower MELD scores were not represented and the sample size is clearly much smaller than 
that of Casadaban et al. Conceptually the inability of MELD score to predict outcome may be due to other factors 
which govern survival not captured in the MELD score such as inflammatory indices, extra-hepatic/renal organ 
failure and regenerative capacity. Finally, our patient cohort were of exclusively alcoholic aetiology. Casadaban et al. 
described non-alcoholic aetiology as predictive of increased mortality on multivariate analysis23 which may be a 
function of diminished regenerative potential compared to patients with alcoholic cirrhosis.
Early TIPSS therapy for variceal haemorrhage in a carefully selected population, has been shown to be 
associated with a significant improvement in survival24. Other studies however have failed to demonstrate an 
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improvement in survival despite an improvement in haemostasis rates25. Complications of TIPSS insertion in 
these populations included exacerbation of a hyper dynamic circulation, increased cerebral blood flow and the 
development of intracranial hypertension with increased encephalopathic grade25,26. Better patient selection and 
early prophylactic use of antibiotics may account for the discrepancies in findings between these studies. Our 
data implicates a gut-derived LPS-driven inflammatory response in pathogenesis and suggests a potential role 
for adjunctive LPS-reducing strategies to further diminish risk of organ failure and mortality induced by TIPSS.
Conclusion
This study provides direct evidence for portal endotoxaemia in refractory variceal haemorrhage and describes the 
magnitude of bacterial translocation in this context. The data suggests that the liver is responsible for compart-
mentalising endotoxaemia and associated neutrophil dysfunction within the portal circulation but this aberrant 
neutrophil phenotype may be reversed by exposure to a different plasma milieu. TIPSS insertion disturbs this 
compartmentalisation and exposes the systemic circulation to portal endotoxaemia and a dysregulated inflam-
matory response syndrome, an adverse prognostic determinant in cirrhosis. This study also suggests an intestinal 
origin of IL-10 in cirrhosis, a possible adaptive response to enterocyte stress due to portal hypertension. The liver 
in contrast is a key generator of IL-6, a prognostic determinant in the context of variceal haemorrhage.
Number of organ failures at presentation was found to be associated with 30, 60 and 90 day mortality. 
LPS-driven SIRS, which drives multiple organ failure and sepsis is an important therapeutic target as evidenced 
by an improvement in mortality with prophylactic antibiotics. This study suggests that LPS-binding strategies, 
certainly in the initial period post-TIPSS insertion may improve neutrophil function and impact on organ failure 
and mortality. Early treatment of high-risk patients with adjunctive therapy to diminish portal endotoxaemia has 
the potential to diminish neutrophil dysfunction, risk of sepsis and survival in a patient group with an otherwise 
unacceptably high mortality.
Methods
Studies were undertaken with the approval of Central London and Lothian Research Ethics Committees and in 
accordance with the Declaration of Helsinki (1951) of the World Medical Association.
Patients. 26 patients with alcoholic cirrhosis were studied prior to and 1-hour after TIPSS insertion. Data 
from 9 of these patients have been described in a previous study12. Patients were included into the study if they 
had clinical, biochemical or histological evidence of cirrhosis and were undergoing TIPSS placement indicated 
for active variceal haemorrhage refractory to endoscopic therapy and within 72 hours of admission. All patients 
were haemodynamically stable at the time of TIPSS insertion and informed consent (from the patient) or assent 
(from next of kin) was obtained. Other exclusion criteria included pregnancy, a diagnosis of diabetes, cardiovas-
cular disease or malignancy.
Management Protocol and Study Design. The patients were managed according to a standardized pro-
tocol, and in accordance with the UK guidelines for variceal hemorrhage. TIPSS insertion was indicated either 
because the patient had variceal bleeding refractory to endoscopic therapy or due to recurrent bleeding despite 
endoscopic therapy. At the time of TIPSS insertion, the patients were mechanically ventilated following sedation 
with propofol and paralysed with atracurium besylate (300–600 μg/kg/hr). Routine invasive and electrocardio-
graphic monitoring was performed. Fluid resuscitation and red cell concentrate were administered in guidance 
with the central venous pressure, mean arterial pressure and the haematocrit. All the patients received broad 
spectrum prophylactic antibiotics as prophylaxis for variceal haemorrhage. No patients were on rifaximin ther-
apy at the time of admission. Data regarding other antibiotic usage was not available. Blood glucose levels were 
maintained between 5–7 mmol/l.
TIPSS procedure and catheter insertion. A single interventional radiologist on each site performed all 
the TIPSS procedures using standard techniques. Pre-TIPSS procedure, a femoral artery was cannulated using 
an 18 gauge needle (Vygon leader company, Ecoven, France). The right internal jugular vein was then punc-
tured and a 10 F sheath (William-Cook, Bjaeverskov, Denmark) introduced. The right or middle hepatic vein 
was selected using a stiff hydrophilic guide wire (Terumo, Hatagaya, Tokyo, Japan) and a fine stylet was used to 
puncture a branch of the portal vein. Blood from the femoral artery (A), hepatic vein (HV) and portal vein (PV) 
sampled before insertion of the TIPSS. An angioplasty balloon catheter was then used to dilate the parenchymal 
tract prior to stent insertion (10 mm Wallstent, Schneider, Bulach, Switzerland). Portal venous and inferior vena 
caval pressures were recorded pre- and post-TIPSS insertion and the portal pressure gradient determined (portal 
venous pressure minus inferior vena caval pressure). One hour after TIPSS insertion blood was sampled from the 
following: femoral artery, hepatic vein (not involving TIPSS-shunt) and portal vein.
Blood sampling and Measurements. Calculations. Intestinal and hepatic fractional extraction rates of 
LPS were calculated according to the following equation using pre-TIPSS plasma levels. The calculation of hepatic 
fractional extraction assumes a 70% contribution from the hepatic artery and 30% contribution from the portal 
vein in this patient cohort. Previous data supports this assumption.
=
− . × + . ×
. + .
Hepatic Fractional Extraction Hepatic vein arterial portal vein
arterial portal vein
[ (0 7 0 3 )]
[0 7 0 3 ]
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=
−Intestinal Fractional Extraction Portal vein arterial
Arterial
[ ]
[ ]
LPS. Heparinized whole blood was drawn with pyrogen-free needles into pyrogen-free tubes and the serum 
separated at 4◽ C and stored at − 80◽ C in pyrogen-free polyethylene cryotubes (Nunc, Rochester, USA) on the day 
of collection. The chromogenic limulus amoebocyte lysate assay (Charles River Laboratories, France) was used 
for detection of LPS. For optimal test results, heparinised plasma with a low concentration of heparin (15IU/ml) 
was used, additionally plasma samples (100 μ L) were diluted 1:10 with LPS-free water and heat treated for 30 minutes 
at 75 °C 100 μ L of sample and 100 μ L of LAL reagent were mixed in a 96-well plate and analysed at 405 nm with a 
spectrophotometer using the EndoscanV® software.
Neutrophil Studies. Neutrophil isolation. Whole blood was layered over 5 ml of Polymorphprep 
(Axis-Shield, Oslo, Norway) and spun for 30 minutes at 400 g at room temperature. Neutrophils were harvested 
from the second interface and washed with phosphate buffered saline (PBS, Sigma Aldrich, St. Louis, MO). 
Neutrophils were counted and re-suspended in PBS at a density of 5 × 105 in 50 μ L; 50 μ L of cell suspension and 
50 μ L of plasma were used per assay. Viability was tested by Trypan blue exclusion and was over 98%.
Neutrophil function. The Phagoburst kit (Orpegen Pharma, Heidelberg, Germany) was used to determine the 
percentage of neutrophils that produce reactive oxidants as previously described (FACS Canto II, BD Bioscience) 
(Mookerjee, Stadlbauer et al.16). 100 μ L of heparinized whole blood or blister neutrophil suspension was 
incubated for 20 minutes with either 20 μ L of opsonized Escherichia coli (2 × 107 bacteria) or without stimu-
lus at 37 °C. The formation of reactive oxidants was monitored by the oxidation of dihydrorhodamine 123 to 
rhodamine. Cells were stained with anti–CD16-PE antibody (Immunotools, Friesoythe, Germany) and analyzed 
by fluorescence-activated cell sorting. Neutrophils were gated using forward and side scatter and the percentage 
of CD16-positive cells producing reactive oxygen metabolites calculated.
The Phagotest (Orpegen Pharma) was used to measure phagocytosis by using FITC-labeled opsonized E. coli 
bacteria as described before (Mookerjee, Stadlbauer et al.16). 100 μ L of either whole blood derived neutrophil 
suspension was mixed with 20 μ L of FITC-labelled E. coli bacteria (2 × 107) at 37 °C for 20 minutes. Fluorescence 
of bacteria at the cell surface was quenched using brilliant blue. To identify neutrophils, cells were stained with 
anti-CD16-PE immunoglobulin G (IOTest; Beckman Coulter) and analyzed by FACS analysis (FACS; Becton 
Dickinson FACS Canto II and FACS Diva 6.0 software, San Jose, CA). Phagocytosis is expressed as the geometric 
mean of fluorescence intensity (GMFI), corresponding to the number of labeled bacteria engulfed by a single cell.
Cytokine expression. Plasma levels of IL-10 and IL-6 were determined using commercially available ELISA 
assays in accordance with manufacturers instructions (R and D Biosystems).
Statistical Analysis. Statistical analysis was performed using Graph Prism Version 7.0. Parametric (paired t-test, 
Pearson) and non-parametric (Mann Whitney, Spearman) analyses were performed as appropriate. Significance 
was considered present at p < 0.05.
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